Pharmaceutical Industry Information Portal

HomeNews

News

WHO Interim Statement on composition of current and future COVID-19 vaccines

Interim Statement on COVID-19 vaccines in the context of the circulation of the Omicron SARS-CoV-2 Variant from the WHO Technical Advisory Group on COVID-19...

Gustave Roussy and Anju Software to Accelerate Complex Oncology Clinical Studies

Anju Software announced that Gustave Roussy, one of the top five cancer research centers in the world and Europe's top-ranked hospital for oncology research, has...

European Medicines Agency receives application for conditional marketing authorisation for Paxlovid

EMA has started evaluating an application for a conditional marketing authorisation for the oral antiviral medicine Paxlovid (PF-07321332 and ritonavir). The applicant is Pfizer...

Nigeria is working to develop a COVID-19 vaccine, President Muhammadu Buhari said

Health experts say Nigeria needs to triple its vaccination drive from just over 100,000 doses a day to meet its target of inoculating more...

GMP-inspections of veterinary manufacturers in the second half of 2021

The review provides information related to the inspection of manufacturers of medicinal products for veterinary use for compliance with the requirements of the Good Manufacturing Practice (GMP).

AstraZeneca and Neurimmune sign exclusive global collaboration to develop and commercialise NI006

Alexion, AstraZeneca’s Rare Disease group, has entered into an exclusive global collaboration and licence agreement with Neurimmune AG for NI006, an investigational human monoclonal...
spot_img

Expert Articles

spot_img